IMR Press / EJGO / Volume 20 / Issue 1 / pii/1999109

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Endometrial stromal sarcoma: a clinicopathologic study

Show Less
1 Departments of Gynecology and Obstetrics, University of Bari, Italy
Eur. J. Gynaecol. Oncol. 1999, 20(1), 33–34;
Published: 10 February 1999

Background: This study is a clinicopathologic evaluation of five patients with endometrial stromal sarcom Patients and Methods: Over a period of 9 years 5 cases of ESS were observed in our Unit. The patients were retrospectively staged according to the FIGO staging system for endometrial cancer. The neoplasm was divided into two groups based on mitotic activity. Patients underwent endouterine curettage, surgery therapy and, except one of them, chemotherapy. Results: Two patients had low-grade ESS stage lb and le. The other three had high-grade ESS, and were in stage IIIa. Treatment was surgery for all patients, and adjuvant chemotherapy for 4 out of 5. Both patients in stage I are alive, clinically free from the disease, 25 and 36 months after diagnosis. In stage III all patients died 14, 25 and 36 months after diagnosis. Conclusion: ESS is a rare uterine neoplasm. Histologic grade is the most important prognostic factor.

Endometrial stromal sarcoma (ESS)
Back to top